| Primary |
| Product Used For Unknown Indication |
61.9% |
| Hyperphosphataemia |
38.1% |
|
| Pruritus |
35.7% |
| Constipation |
21.4% |
| Hyperphosphataemia |
14.3% |
| Abdominal Discomfort |
7.1% |
| Dizziness |
7.1% |
| Medication Error |
7.1% |
| Post Procedural Constipation |
7.1% |
|
| Secondary |
| Product Used For Unknown Indication |
48.2% |
| Hyperphosphataemia |
25.9% |
| Prophylaxis |
10.2% |
| Hyperparathyroidism |
3.0% |
| Hyperparathyroidism Secondary |
3.0% |
| Chronic Myeloid Leukaemia |
2.0% |
| Cardiac Failure |
1.5% |
| Congenital Cystic Kidney Disease |
1.0% |
| Hypertension |
1.0% |
| Nephrogenic Anaemia |
1.0% |
| Abdominal Distension |
0.5% |
| Gastritis |
0.5% |
| Hyperkalaemia |
0.5% |
| Hyperuricaemia |
0.5% |
| Hypothyroidism |
0.5% |
| Renal Cell Carcinoma |
0.5% |
|
| Rash |
14.3% |
| Anaemia |
7.1% |
| Dyspepsia |
7.1% |
| Medication Error |
7.1% |
| Pharyngitis |
7.1% |
| Splenic Calcification |
7.1% |
| Abdominal Discomfort |
3.6% |
| Angina Pectoris |
3.6% |
| Arrhythmia |
3.6% |
| Drug Ineffective |
3.6% |
| Gastrointestinal Disorder |
3.6% |
| Haemorrhagic Stroke |
3.6% |
| Hyperphosphataemia |
3.6% |
| Hypertension |
3.6% |
| Hypothyroidism |
3.6% |
| Interstitial Lung Disease |
3.6% |
| Large Intestine Perforation |
3.6% |
| Pruritus |
3.6% |
| Renal Failure Acute |
3.6% |
| Vomiting |
3.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
35.9% |
| Product Used For Unknown Indication |
29.8% |
| Hyperparathyroidism Secondary |
7.0% |
| Hyperphosphataemia |
6.6% |
| Hypertension |
6.5% |
| Renal Failure Chronic |
1.5% |
| Metastatic Renal Cell Carcinoma |
1.4% |
| Hyperparathyroidism |
1.1% |
| Nephrogenic Anaemia |
1.1% |
| Hiv Infection |
1.0% |
| Haemodialysis |
0.9% |
| Nuclear Magnetic Resonance Imaging |
0.9% |
| Renal Failure |
0.9% |
| Anaemia |
0.9% |
| Mantle Cell Lymphoma |
0.9% |
| Prophylaxis |
0.9% |
| Insomnia |
0.8% |
| Depression |
0.7% |
| Pain |
0.7% |
| Acute Myeloid Leukaemia |
0.6% |
|
| Vomiting |
12.7% |
| Traumatic Fracture |
7.6% |
| Death |
6.8% |
| Myocardial Ischaemia |
6.8% |
| Transplant Rejection |
5.9% |
| Atrial Fibrillation |
5.1% |
| Hyperphosphataemia |
5.1% |
| Venoocclusive Disease |
5.1% |
| Cerebrovascular Accident |
4.2% |
| Electrocardiogram Qt Prolonged |
4.2% |
| Myocardial Infarction |
4.2% |
| Renal Failure Chronic |
4.2% |
| Skin Ulcer |
4.2% |
| Cardiac Failure |
3.4% |
| Cerebral Infarction |
3.4% |
| Diarrhoea |
3.4% |
| Hyperkalaemia |
3.4% |
| Pneumonia |
3.4% |
| Pulmonary Oedema |
3.4% |
| Road Traffic Accident |
3.4% |
|
| Interacting |
|
| Inhibitory Drug Interaction |
100.0% |
|
